Prevest Denpro's Q4 Financial Results Show Decline in Profitability and Revenue, Debt to Equity Ratio at Highest in Five Quarters

Net Profit - Quarterly: Lowest at Rs 2.85 cr. in the last five quarters. Company's profitability has declined.
Earnings Per Share (EPS) - Quarterly: Lowest at Rs 1.02 in the last five quarters. EPS has decreased by 50% compared to the previous quarter.
Revenue - Quarterly: Lowest at Rs 13.63 cr. in the last five quarters. Company's revenue has decreased by 10% compared to the previous quarter.
Debt to Equity Ratio - Quarterly: Highest at 0.01 in the last five quarters. Company's debt to equity ratio has increased, indicating higher financial risk.

Despite these challenges, Prevest Denpro remains a strong player in the medical equipment/supplies/accessories industry. As a microcap company, it has shown resilience in the face of a tough market. However, according to MarketsMOJO, the stock call for Prevest Denpro is currently 'Sell'.

Investors should take note of the company's financial performance and make informed decisions. It is important to consider all factors before making any investment decisions. Prevest Denpro's financial results for the quarter ending December 2023 have been declared on February 3, 2024. Stay tuned for further updates on the company's performance.